Human Dendritic Cells Derived From Embryonic Stem Cells Stably Modified With CD1d Efficiently Stimulate Antitumor Invariant Natural Killer T Cell Response - cytomed
Menu
Home
About
About Us
Our Team
Our Collaboration Partner
Manufacturer
Publications
Briefs
Platform
CAR-γδ T Cell
iPSC-γδ NKT Cell
Pipeline
Investor
Investor Relations
Financial Reports
Banking Services
Contact Us
Shareholder Benefits
Make An Appointment
Human Dendritic Cells Derived From Embryonic Stem Cells Stably Modified With CD1d Efficiently Stimulate Antitumor Invariant Natural Killer T Cell Response
«
Antigenically Modified Human Pluripotent Stem Cells Generate Antigen-Presenting Dendritic Cells
Enhancing Immunostimulatory Function of Human Embryonic Stem Cell-Derived Dendritic Cells by CD1d Overexpression
»
